Jaguar Health Inc (JAGX) Is Down -44.72% in 2024 With Lots of Room to Run

Jaguar Health Inc (NASDAQ: JAGX) is -44.72% lower on its value in year-to-date trading and has touched a low of $0.09 and a high of $4.37 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The JAGX stock was last observed hovering at around $0.09 in the last trading session, with the day’s loss setting it -0.01%.

Currently trading at $0.08, the stock is -17.14% and -49.14% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 14.52 million and changing -5.64% at the moment leaves the stock -78.97% off its SMA200. JAGX registered -98.00% loss for a year compared to 6-month loss of -85.72%. The firm has a 50-day simple moving average (SMA 50) of $3.41 and a 200-day simple moving average (SMA200) of -$1.23.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The stock witnessed a -27.22% gain in the last 1 month and extending the period to 3 months gives it a -71.24%, and is -13.53% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.36% over the week and 13.09% over the month.

Profit margin for the company is -370.40%. Distance from 52-week low is -2.22% and -98.08% from its 52-week high. The company has generated returns on investments over the last 12 months (-120.82%).

Jaguar Health Inc quarterly earnings per share for the current quarter are estimated at $0 with sales reaching $2.61M over the same period., but quarterly earnings will post -22.00% year-over-year. Quarterly sales are estimated to shrink -19.90% in year-over-year returns.

Jaguar Health Inc (JAGX) Top Institutional Holders

18 institutions hold shares in Jaguar Health Inc (JAGX), with institutional investors hold 1.63% of the company’s shares. The shares outstanding are 50.76M, and float is at 40.48M with Short Float at 10.16%. Institutions hold 1.37% of the Float.

The top institutional shareholder in the company is Geode Capital Management, LLC with over 92333.0 shares valued at $47643.0. The investor’s holdings represent 0.48% of the JAGX Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 79565.0 shares valued at $41055.0 to account for 0.42% of the shares outstanding. The other top investors are Morgan Stanley which holds 55985.0 shares representing 0.29% and valued at over $28888.0, while Blackrock Inc. holds 0.27% of the shares totaling 51212.0 with a market value of $26425.0.

Jaguar Health Inc (JAGX) Insider Activity

A total of 9 insider transactions have happened at Jaguar Health Inc (JAGX) in the last six months, with sales accounting for 0 and purchases happening 9 times.